All News #Library
Others
Sentien Partners with BARDA to Evaluate High Dose Cohort of SBI-101
03 Sep 2021 //
PRWEB
Sentien Announces First Subject Dosed in Phase 1/2 Trial of Ex Vivo MSC
23 Nov 2020 //
PRWEB

Market Place
Sourcing Support